DR. MEREDITH RAE BAKER MD NPI 1316161680

NPI Details

DR. Meredith Rae Baker, MD is an urology in Bend, OR with 24 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Meredith Rae Baker, MD NPI is 1316161680. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:2002

The provider's business location address is:

2090 NE WYATT CT
SUITE 101
BEND, OR
ZIP 97701-687
Phone: (541) 382-6447
Fax: (541) 330-7413

The NPI 1316161680 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Urinalysis using microscope (HCPCS:81015)
• Urinalysis, manual test (HCPCS:81002)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Insertion of lower leg neurostimulator electrode (HCPCS:64566)
• Urine microalbumin (protein) level (HCPCS:82043)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming (HCPCS:95971)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Biopsy of bladder using an endoscope (HCPCS:52204)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Blood creatinine level (HCPCS:82565)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Insertion of sacral nerve neurostimulator electrode array (HCPCS:64561)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Biopsy of prostate gland (HCPCS:55700)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 4/11/2007 and was last updated on 3/29/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.